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Nuclear bodies (NBs), characterized by the presence
of the promyelocytic leukemia (PML) protein, are
important components of the nuclear architecture,
contributing to genetic and epigenetic control of
gene expression. In investigating the mechanisms
mediatingHIV-1 latency,wedetermined that silenced
but transcriptionally competent HIV-1 proviruses
reside in close proximity to PMLNBs and that this as-
sociation inhibits HIV-1 gene expression. PML binds
to the latent HIV-1 promoter, which coincides with
transcriptionally inactive facultative heterochromatic
marks, notably H3K9me2, at the viral genome. PML
degradationandNBdisruption result in strongactiva-
tion of viral transcription aswell as release of G9a, the
major methyltransferase responsible for H3K9me2,
and loss of facultative heterochromatin marks from
the proviral DNA. Additionally, HIV-1 transcriptional
activation requires proviral displacement from PML
NBs by active nuclear actin polymerization. Thus,
nuclear topology and active genemovementmediate
HIV-1 transcriptional regulation and have implica-
tions for controlling HIV-1 latency and eradication.
INTRODUCTION
Functional compartmentalization of the eukaryotic cell nucleus
has implications for all aspects of genome function. In particular,
gene localization within specialized nuclear compartments
essentially regulates gene expression (Takizawa et al., 2008;
Zhao et al., 2009). Active genes tend to localizewithin the nuclear
interior but can also associate with nuclear speckles or the
nuclear pore complex. Other nuclear neighborhoods, such as
the nuclear membrane/lamina, and the perinucleolar chromatin
are associated with transcriptionally silent loci or gene-poor
chromosomal regions (Brown et al., 1997; Finlan et al., 2008).
An important feature of these associations between various
loci and subnuclear domains is that they are dynamic and can
change in response to cellular signals.Cell HOne prominent nuclear structure, known as the promyelocytic
leukemia (PML) nuclear body (NB), has been diversely associ-
ated to a number of cellular functions, ranging from cellular pro-
tein modification to antiviral defense (reviewed in Bernardi and
Pandolfi, 2007; Lallemand-Breitenbach and de The´, 2010). This
compartment is characterized by the prominent localization of
the PML protein (also known as Trim19), which belongs to the
large family of Tripartite motif (TRIM) proteins, the members of
which display antiretroviral properties (Nisole et al., 2005). The
PML protein partitions between the nucleoplasmic fraction and
the nuclear matrix-associated PML NBs (Bernardi and Pandolfi,
2007; Lallemand-Breitenbach and de The´, 2010). These are
complex structures, rich in more than 200 cellular proteins
besides PML itself (Van Damme et al., 2010), which are regulated
by various cellular stresses, including viral infection, DNA dam-
age, cell transformation, and oxidative stress (Bernardi and
Pandolfi, 2007). Specific DNA regions are known to localize in
close proximity to PML NBs. In human primary fibroblasts, these
compartments were reported to associate with the MHC/Oct3-4
gene cluster in chromosome 6 and proposed to modulate the
chromatin architecture and transcription of this gene group
(Kumar et al., 2007; Shiels et al., 2001). Cellular infection with
different viruses is known to profoundly modify PML NB number,
distribution, and content; in addition, the genomes of certain
DNA viruses are known to accumulate at the periphery of PML
NBs during infection of quiescent cells (Bernardi and Pandolfi,
2007; Everett et al., 2007; Lallemand-Breitenbach and de The´,
2010).
Despite these associations with specific cellular and viral DNA
sequences, PML NBs are usually considered as nuclear struc-
tures devoid of DNA. Considering that the PML protein associ-
ates with the nuclear matrix, it is plausible that PML NBs serve
to anchor and regulate various nuclear functions, including
DNA replication and transcription, by controlling the chromatin
architecture of the associated DNA sequences (Kumar et al.,
2007).
HIV-1 efficiently infects metabolically active CD4+ T cells, in
particular activated T-lymphocytes and macrophages (Manga-
naro et al., 2010). In these cells, including primary CD4+ T lym-
phocytes from HIV-1-infected patients, integration into the host
cell DNA preferentially occurs in correspondence to actively
transcribed genes. Once CD4+ T-lymphocytes revert to a rest-
ing, memory state, HIV-1 undergoes reversible transcriptionalost & Microbe 13, 665–677, June 12, 2013 ª2013 Elsevier Inc. 665
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represent a major source of HIV-1 reservoirs, since these cells,
not expressing any viral protein, are refractory to the current
antiretroviral therapies, which only target the replicative fraction
of the virus. Understanding the mechanisms regulating viral
latency and reactivation, therefore, appears of paramount impor-
tance for the development of novel antiviral therapies aimed at
HIV-1 eradication.
Transcription of the integrated HIV-1 virus is driven by the 50
long terminal repeat (LTR) promoter that contains binding sites
for several cellular transcription factors. Over the past years, we
have extensively investigated protein-DNA interactions at the
proviral DNA and discovered that most transcription factors
are effectively bound to their target sites in both the latent
and the activated states (Della Chiara et al., 2011; Lusic et al.,
2003). What distinguishes these states, however, is the epige-
netic regulation of chromatin conformation. Chromatin immuno-
precipitation (ChIP) experiments have indeed demonstrated
that modification of chromatin in proximity of the HIV-1 tran-
scription start site precedes the onset of polymerase (Pol II)-
driven transcription and is essential for viral gene expression
to occur (Lusic et al., 2003). The actual molecular mechanisms
that restrict HIV-1 gene expression in resting cells and deter-
mine latency, however, have remained largely elusive. An
intriguing possibility is that the regulation of HIV-1 transcription
might correlate with nuclear topology and thus depend on
the localization of the proviral DNA inside the nucleus of the
infected cells.
Here, by immuno-3D-fluorescent in situ hybridization
(immuno-FISH), we report that, in the nucleus of latent CD4+
T cells, the HIV-1 provirus associates with the PML NB environ-
ment and that this interaction inhibits HIV-1 gene expression.
Repression is mediated by anchoring, onto the viral DNA, the
histone methyltransferase G9a, which induces bimethylation of
histone 3 lysine 9 and the formation of facultative heterochro-
matin. During transcriptional reactivation, HIV-1 repositions its
genome away from PML NBs through an active movement
requiring nuclear actin polymerization.
RESULTS
The HIV-1 Provirus Resides in Close Proximity to PML
Nuclear Bodies in Latent J-Lat Jurkat Cell Clones
We explored the spatial relationship between the HIV-1 provirus
and PMLNBs by 3D-FISH combinedwith immunostaining. A first
set of experiments was performed in three clones of chronically
infected Jurkat CD4+ T cells (J-Lat 9.2, J-Lat 6.3, and J-Lat 8.4;
Jordan et al., 2003). These clones harbor a full-length HIV provi-
rus with the GFP gene replacing the viral nef gene and represent
a bona fide cellular model for HIV-1 latency. In these clones, the
distance between the provirus and the nearest PML body was
determined by 3D immuno-DNA FISH, performed according to
a method that preserves the 3D structure of the nucleus (Solovei
and Cremer, 2010). The proviral DNA and PML were labeled by
hybridization with a FITC-labeled probe and by a Cy5-conju-
gated antibody, respectively. Representative, single confocal
images for clone J-Lat 9.2, obtained in unstimulated conditions
or after 5 and 48 hr of TPA treatment, are shown in Figure 1A
(HIV-1 colored in green and PML in red).666 Cell Host & Microbe 13, 665–677, June 12, 2013 ª2013 ElsevierAfter 3D reconstruction of these confocal images, the center-
to-center distance between the provirus and its closest PML NB
was measured in at least 100 cells. The results showed the
progressive displacement of the HIV-1 provirus from the PML
NBs over time upon TPA treatment. The distances were then
normalized to the nuclear diameter, and the distribution was rep-
resented by box plot analysis (Figure 1B). Statistical analysis
confirmed that there was a significant difference in the observed
displacements (p < 0.001 for both analyzed time points com-
pared to untreated cells).
Next, we sought to determinewhether the histone deacetylase
(HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA or
vorinostat) also affected the spatial distribution of PML NB and
HIV-1 provirus. SAHA is a class I HDAC inhibitor, shown to
induce HIV promoter expression in vitro (Archin et al., 2009; Con-
treras et al., 2009), as well as in vivo and ex vivo (Archin et al.,
2012). The J-Lat 9.2 clone treated with 1 mM SAHA for 48 hr
was used to assess the distances between the HIV-1 provirus
and the closest PML NB. The measured distances, normalized
to the nuclear diameter, increased significantly with respect to
the control cells (p > 0.001) (representative, single confocal
images in Figure 1A and quantification in Figure 1B). The total
number of PML bodies (see Figure S1A online) and the total
levels of PML protein (cf. later, Figure 3A) did not change upon
TPA or SAHA treatments.
A similar analysis, performed in J-Lat clone 6.3, showed a
remarkable colocalization of the provirus with PML NB in unsti-
mulated cells, which was progressively lost upon TPA treatment
(Figure 1C). Statistical analysis of the distribution of measure-
ments again indicated high significance of the detected differ-
ences (p < 0.001 for both time points; Figure 1D).
Finally, analogous findings were also obtained for clone J-Lat
8.4. Also in this case, the vast majority of integrated HIV-1 colo-
calized with PMLNB in resting conditions, while it detached from
it upon cell treatment with TPA (Figures S1C and S1D).
As a control, we used a region of theMHCclass I locus of chro-
mosome 6, which was shown to associate with PML NBs (Wang
et al., 2004), and with a specific BAC that maps to this region, we
confirmed the tight association between PML territories and
MHC I in the J-Lat clone 9.2 (Figure S1E). Similar to what was
observed for HIV-1, the distance between this locus and the
closest PML body increased upon stimulation with TPA (p <
0.001; Figure S1F).
Taken together, these results indicate that transcriptional
silencing of integrated HIV-1 occurs when it is positioned in close
proximity to PML NBs in different clones of latently infected
Jurkat cells.
Latent HIV-1 Is Found in Close Proximity of PML Nuclear
Bodies in Primary CD4+ T Cells
We wanted to verify whether the dynamic relationship between
PMLNBs and integrated HIV-1 also occurred in primary, infected
CD4+ T cells. For this purpose, we took advantage of a recently
developed primary cell model of latency, in which primary human
CD4+ cells generate ex vivo a large number of cells latently
infected with HIV-1 (Bosque and Planelles, 2011). Peripheral
blood naive CD4+ T lymphocytes from normal donors (n = 6)
were stimulated with anti-CD3/CD28 beads and cultured first
in the presence of TGF-b, IL-4, and IL-12 and later IL-2. The cellsInc.
Figure 1. HIV-1 Provirus Resides in Close Proximity of PML Nuclear Bodies in J-Lat 9.2 and 6.3 Latent Cell Clones
(A) Representative images of 3D immuno-DNA FISH of control, TPA-treated (5 or 48 hr), and SAHA-treated (48 hr) J-Lat 9.2 cells. HIV-1 genome, green;
PML, red.
(B) Box plot graphs showing the distribution of 3D measurements of the minimum separation distance between the integrated latent provirus and the closest
PML NB, normalized for the nuclear diameter (n = 100 cells). ***p < 0.001.
(C and D) (C) As in (A), except for the SAHA treatment. (D) As in (B) for the J-Lat 6.3 clone.
Related to Figure S1.
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with HIV-1 obtained from the Env- molecular clone pNL4-3/
ER, which performs a single-round infection once pseudo-
typed with VSV-G (Connor et al., 1995). The infected cells were
kept in culture for 12–13 days to enter a resting state, after
which they were reactivated by restimulation with anti-CD3/
CD28 beads (Figure 2A). The levels of HIV-1 gene expression
increased over 50 times when the resting cells were reactivated
(Figure 2B).
3D immuno-DNA FISH for proviral DNA and PML was per-
formed in the two conditions, with representative images for
latent and reactivated cells shown in Figure 2C and Figure 2D,
respectively. Measurements were performed on >150 cells
from three different donors, and in agreement with J-Lat clones
we again observed that the provirus resided in close proximity of
the PML NB in the latent state. The displacement of HIV-1 from
the closest PML NB after reactivation showed high statistical
significance (p < 0.001; Figure 2E).
These data obtained in latent, primary CD4+ T cells con-
firmed that the silent HIV-1 provirus resides in close proximity
to PML NBs and that, during transcriptional reactivation,
displacement of the viral genome from these subnuclear struc-
tures occurs.Cell HPML Knockdown Releases a Block in HIV-1
Transcription
Our FISH data raised the possibility that PML bodies impose a
block that restricts viral transcription. To address this issue,
we induced the downregulation of endogenous PML by two
approaches: treatment with arsenic trioxide and shRNA-medi-
ated knockdown.
Recent evidence indicates that arsenic targets the wild-type
PML protein directly, by binding to the cysteine residues in
zinc fingers located within the RBCC domain (Zhang et al.,
2010). The treatment of J-Lat clones 9.2 and 6.3 by 1 mM
arsenic trioxide for 24 hr markedly reduced the levels of
PML protein, while TPA left them unaffected (Figure 3A); this
concentration of arsenic did not decrease cell viability (Fig-
ure S2A). The effect of PML degradation on HIV-1 gene expres-
sion was monitored by analyzing the levels of GFP fluorescence
by flow cytometry. As shown in Figure 3B for clone J-Lat
9.2 and in Figures S2C and S2D for J-Lat 6.3 and J-Lat 8.4,
respectively, arsenic caused massive activation of GFP expres-
sion, with the number of GFP-positive cells raising from 5%–
7% in the untreated cells to over 60%–80% in the different
analyzed clones. In the same clones, the levels of HIV-1
transcripts, analyzed by real-time PCR, increased dramaticallyost & Microbe 13, 665–677, June 12, 2013 ª2013 Elsevier Inc. 667
Figure 2. PML NBs Are Associated with Latent HIV-1 Provirus in Primary CD4+ T Cells
(A) Schematic representation of the experimental protocol used for the generation of latently infected human primary CD4+ T cells and their reactivation.
(B) Levels of HIV-1 mRNA in latently infected and reactivated CD4+ primary cells, determined by real-time RT-PCR. Data are represented as mean ± SEM,
p < 0.001.
(C and D) Representative images of 3D immuno-DNA FISH of latent (n = 150) and reactivated, infected primary CD4+ T cells (n = 120). HIV-1 genome, green;
PML, red.
(E) Distribution of 3D measurements of the minimum separation distance between the integrated latent provirus and the closest PML NB, normalized for the
nuclear diameter. **p < 0.01.
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and J-Lat 9.2; Figure 3C).
Next, we stably transduced the J-Lat clones 9.2 and 6.3 with a
lentiviral vector expressing the puromycin-resistance gene and
containing an shRNA that targets all PML isoforms (Kuroki
et al., 2009), and we selected puromycin-resistant clones. PML
knockdown in transduced clones was verified by both western
blotting (Figure 3D) and immunofluorescence using an antibody
against PML (data not shown). Remarkably, more than 90% of
the transduced cells were found to have reactivated the HIV-1
LTR-driven GFP expression, as detected by flow cytometry (Fig-
ure 3E). The levels of HIV-1mRNA upon knockdown of PMLwere
found to be dramatically upregulated (>200- and > 300-fold in-
crease for the J-Lat 9.2 and 6.3 clones, respectively). These
levels were comparable to those obtained upon stimulation of
the parental cells with 5 hr TPA treatment (Figure 3F). As a control
for these experiments, we used a nontargeting lentiviral vector
and an empty lentiviral vector; no changes in PML protein
levels—nor in HIV-1 transcription—were observed with these
controls.
To understand whether reactivation of HIV-1 gene expression
upon PML knockdown was a consequence of a broader reacti-
vation of cellular gene transcription, we analyzed, by deep
sequencing, the transcriptome in the PML knockdown J-Lat
9.2 clone (PMLi) and compared the results obtained with the
transcriptome from control and TPA-treated JLat 9.2 cells
(Figure S2E). Despite the strong upregulation of viral transcrip-
tion imparted by both anti-PML RNAi and TPA, correlation
between the transcript levels was poor between these two
kinds of treatments (Figure S2F), and the transcriptome of the668 Cell Host & Microbe 13, 665–677, June 12, 2013 ª2013 ElsevierPMLi cells was more similar to that of the untreated cells than
to that of cells treated with TPA (Figure S2G). In particular,
PML depletion from the cells did not activate any of the sig-
naling pathways that are otherwise activated by TPA in lymphoid
cells (Figure S2H). These results strengthen the conclusion that
the repressive effect of PML on HIV-1 transcription is rather
specific.
Finally, we examined the effect of PML removal by arsenic
treatment in primary, latently infected CD4+ T cells. At 14 days
after infection with HIV-1 pNL4-3/ER, a time point when the
cells are in the resting phase and viral gene expression is
silenced (cf. Figure 2B), arsenic trioxide 1 mM was added to the
cell culture. This treatment significantly reduced the levels of
endogenous PML (Figure 3G), paralleled by a massive increase
in viral gene expression (>60-fold over mRNA extracted from
untreated, latent cells; Figure 3H).
PML Binds the Latent Provirus Chromatin Modified with
H3K9me2, a Facultative Heterochromatin Mark
Next, we probed the association of PML with the HIV-1 genomic
sequences by ChIP, using primers spanning the LTR promoter
(PPR1), the region immediately downstream the transcription
start site corresponding to the position of nucleosome-1
(Nuc1A), the provirus sequence (JLatA, which corresponds to
the 50 end of the gag gene; JLatB; and JLatC) and a control
region on chromosome 19 (B13; Figure 4A). We prepared chro-
matin from J-Lat 9.2 cells treated with TPA or with the solvent
control and immunoprecipitated it with antibodies against
PML. Real-time PCR analysis of the immunoprecipitated mate-
rial showed that PML was present at both the silent viralInc.
Figure 3. HIV-1 Transcription Is Reactivated
upon PML Removal
(A) PML protein levels in whole-cell lysates of J-Lat
9.2, treated with TPA or with arsenic trioxide or
J-Lat 6.3 treated with arsenic, were assessed
by immunoblot for PML levels or total a-tubulin
protein levels.
(B) Flow cytometry profiles of J-Lat 9.2 cells in the
absence of stimulation, treated with TPA or with
arsenic; the upper right gate shows GFP-positive
cells. The percentage of cells in each quadrant is
shown.
(C) RT-PCRmeasurement of HIV-1mRNA levels in
mock- or arsenic-treated J-Lat clones 9.2, 6.3,
and 8.4 normalized over the 18S housekeeping
gene. Data are represented as mean ± SEM.
Arsenic versus control, p < 0.001 for all three
clones.
(D) Immunoblot detection of PML protein levels,
in J-Lat 9.2 or 6.3 clones stably expressing an
shPML. C, parental cell clone. Vector, molecular
clones obtained by transduction of the pLKO-nt, in
case of the 9.2 clone or pLV THM empty vector, for
clone 6.3.
(E) Flow cytometry for GFP fluorescence in J-Lat
clones stably transduced with the indicated
vectors.
(F) Levels of HIV-1mRNA, determined by real-time
RT-PCR, in the J-Lat clones stably transduced
with the indicated vectors, or in parental cells
treated with TPA (5 hr). Data are represented as
mean ± SEM. P, not significant between control
and not targeting; p < 0.001 between either pLV-
shPML or TPA and control.
(G and H) Levels of PML protein (G) and of HIV-1
mRNA (H) in latently infected primary CD4+ T cells
treated with arsenic. In (H), data are represented
as mean ± SEM, p < 0.001 between control and
arsenic.
Related to Figure S2.
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from all the viral sequences upon TPA stimulation (Figure 4B).
Similar results were also obtained with J-Lat clone 6.3 (Figures
S3A–S3C). We also probed, in the J-Lat 9.2 clone, the possible
binding to the viral genome of Daxx and Sp100 proteins, two
constitutive components of the PML NBs (Tavalai and Stam-
minger, 2008). These ChIP experiments revealed marginal bind-
ing of Sp100, irrespective of TPA treatment, and no binding of
Daxx (Figures S3D–S3F).
To characterize the chromatin signatures present concomitant
with PML at the silent and activated HIV-1 provirus, we immuno-
precipitated chromatin with antibodies recognizing differentCell Host & Microbe 13, 665–6chromatin methyl marks. The pattern
of distribution of H3K9me2, a marker
of facultative heterochromatin within
euchromatic regions (Trojer and Rein-
berg, 2007), paralleled that of PML, in
particular being enriched in latent cells
and depleted in activated cells from
both the promoter and the downstream
sequences (Figure 4C). In contrast, thepattern of binding of H3K4me3 (labeling actively transcribed
euchromatin) was somewhat opposed to those of PML and
H3K9me2, becoming remarkably high upon TPA treatment
(Figure 4D).
TPA treatment also determined the release of PML from the
cellular IL-2 gene, which was previously shown to interact with
this factor (Lo et al., 2008; Nayak et al., 2009; Figure S3G). This
treatment also determined a decrease in H3K9me2 marking at
both the IL-2 promoter and coding regions (Figure S3H). Of inter-
est, while TPA determined a strong increase in IL-2 transcription,
the effects of the stable PML knockdown were more modest
(Figure S3I).77, June 12, 2013 ª2013 Elsevier Inc. 669
Figure 4. PML Protein Binds the Latent Provirus Chromatin Marked with H3K9met2, a Facultative Heterochromatin Mark
(A) Primer position along the HIV-1 sequence, with the indication of the transcription factor binding sites and the nucleosomal arrangement in correspondence to
promoter and transcription start site. B13 refers to a control, genomic region mapping to chromosome 19p13.3.
(B–D) ChIP analysis of the chromatin preparations from control and TPA-treated J-Lat 9.2 using anti-PML (B), -H3K9met2 (C), -H3K4met3 (D) antibodies. p < 0.01
for TPA-treated versus control for all the investigated HIV-1 regions except PPR1 in all panels and JLatB and JLatC in (D).
(E and F) ChIP with anti-PML antibody in control and arsenic-treated J-Lat 9.2 cells (E) or after stable knockdown of PML by shPML lentiviral vector (F), using pLV
THM-transduced cells as a control. p < 0.01 for arsenic-treated or shPML-treated versus control for all the investigated HIV-1 regions.
(G and H) Same as (E) and (F) using an anti-H3K9met2 antibody.
(I) Same as (F) and (H) using anti-H3K4met3 antibodies. p < 0.01 for arsenic-treated or shPML-treated versus control for the Nuc1A and JlatA regions in both
panels.
For each antibody, values were normalized for the input amounts of chromatin and the amount immunoprecipitated by a control, anti-IgG antibody. Themean and
SEM values from at least three independent samples are shown for each primer set.
Related to Figure S3.
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PML Removal
We also wanted to study the same chromatin modifications in
J-Lat clone 9.2 upon arsenic treatment or PML knockdown. In
these settings, no proviral DNA sequences could be immunopre-
cipitated with anti-PML antibody (Figures 4E and 4F). Concomi-
tant with a marked increase in proviral gene expression (cf.
Figure 3C), a substantial loss of the repressive chromatin mark670 Cell Host & Microbe 13, 665–677, June 12, 2013 ª2013 ElsevierH3K9me2 at the viral Nuc1A and JLatA sequences was
observed in arsenic-treated cells (Figure 5G) or in cells express-
ing anti-PML shRNA (Figure 5H). In contrast, PML removal deter-
mined a considerable increase in the levels of H3K4me3 at viral
sequences downstream of the nucleosome-free region, ampli-
fied with PPR1 and JLatA primers (Figure 5I).
SAHA treatment (1 mM for 48 hr), despite causing only a
modest increase in HIV-1 mRNA levels (Figure S3J) comparedInc.
Figure 5. G9a Methyltransferase Requires PML Protein to Bind the Viral Genome
(A) ChIP with G9a antibody in control J-Lat 9.2 cells, untreated or treated with TPA or arsenic, or transduced with pLVshPML. Data are represented as mean ±
SEM, p < 0.001 between control and all treated samples.
(B) G9a and PML protein levels in insoluble and soluble nuclear fractions of control and TPA-treated cells. PARP-1protein served as a loading control. Asterisk
stands for the unspecific band.
(C) Immunoblot for G9a in whole-cell lysates (WCL) from control or shPML-expressing cells; tubulin served as a loading control.
(D) Immunofluorescence for G9a (green) and PML (red) in control, TPA-treated, or pLV shPML-transduced cells.
(E) Immunoblot for PML (upper panel) or G9a (lower panel) of G9a immunoprecipitated J-Lat 9.2 nuclear extracts.
(F) Immunoblot for G9a (upper panel) or Flag (lower panel) of Flag-immunoprecipitated HEK293 cells transfected with Flag-PML IV.
(G) Immunoblot for G9a and H3K9me2 in J-Lat 9.2 clones stably transduced with pLKO-NT or pGIP-Z shG9a lentiviral constructs.
(H) Flow cytometry profiles of J-Lat 9.2 cells transduced with indicated vectors.
(I) HIV mRNA levels in the same cells. Data are represented as mean ± SEM, p < 0.001 between either control and the shG9a-treated sample.
(J) HIV mRNA levels in primary latent CD4+ cells treated with indicated drugs. Data are represented as mean ± SEM, p < 0.05 between arsenic- and BIX-1294-
treated cells.
Related to Figure S4.
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ing and determined a loss of the H3K9me2 mark (Figures S3K
and S3L).Cell HTogether, these results suggest that binding of PML with the
provirus correlates strictly with the presence of chromatin marks
suppressive of gene expression.ost & Microbe 13, 665–677, June 12, 2013 ª2013 Elsevier Inc. 671
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G9a to the Viral Genome
Since the H3K9me2 mark was significantly decreased on the
viral DNA sequences upon PML knockdown, we tested whether
the PML protein might mediate association of G9a, the major
methyltransferase responsible for H3K9 dimethylation (Rice
et al., 2003), to the provirus. We immunoprecipitated chromatin
from the J-Lat clone 9.2 with a specific G9a antibody, and we
observed binding of this histone methyltransferase to the viral
sequences in unstimulated cells (Figure 5A). Activation of the
viral promoter with either TPA, arsenic, or SAHA, all of which
decreased H3K9met2, coincided with a strong depletion of
G9a from the provirus (Figure 5A and Figure S4). Similarly,
knockdown of PML using the pLV shPML lentiviral vector also
caused a decrease in provirus-bound G9a. The total levels of
G9a protein in the nuclear fraction did not show any significant
changes upon induction of the cells with TPA (Figure 5B); neither
did they change upon PML knockdown, as shown by immuno-
blotting (Figure 5C) and immunofluorescence (Figure 5D). We
then assessed the direct binding between PML and G9a, by im-
munoprecipitating endogenous G9a protein from the J-Lat 9.2
nuclear extracts followed by immunoblotting for PML (Figure 5E).
This interaction was confirmed on exogenously expressed Flag-
PML-IV isoform that coimmunoprecipitated G9a in HEK293
cells.
Next we stably transduced the J-Lat clone 9.2 with pGZIP-
G9a lentiviral vector, selected stable clones, and controlled the
efficiency of knockdown by immunoblotting with anti-G9a and
anti-H3K9me2 (Figure 5G). Remarkably, more than 90% of the
transduced cells reactivated GFP expression, as detected by
flow cytometry (Figure 5H). The levels of HIV-1 mRNA upon
G9a knockdown increased sharply, as compared to control cells
transduced with a pLKO-nontargeting lentiviral vector (>200-
fold) (Figure 5I). Finally, the effect of G9a inhibition in primary,
latently infectedCD4+ cells was examined by adding the specific
G9a inhibitor BIX01294 (Imai et al., 2010) to the cell culture. This
treatment markedly activated viral gene expression (>20-fold),
even if not as strong as arsenic (>60-fold; Figure 5J).
Displacement of the HIV-1 Provirus from PML NBs Is
Necessary for Viral Transcriptional Activation
Our FISH and ChIP results demonstrate that HIV-1, when tran-
scriptionally silent, colocalizes with PML NBs and that activation
of transcription results in repositioning of the provirus away from
the PML-rich neighborhood. In a growing number of cases, repo-
sitioning of specific cellular genomic sequences to different re-
gions of the nucleus requires active nuclear actin polymerization
(Skarp and Vartiainen, 2010). We therefore wanted to test the
possibility that nuclear actin might also be involved in HIV-1 tran-
scriptional activation. J-Lat 9.2 cells were treated for 1.5 hr with
cytochalasin D (CytD), a powerful inhibitor of actin polymeriza-
tion, before activation with TPA for additional 5 hr. Alternatively,
we first treated the cells with TPA for 5 hr, followed by 1.5 hr
treatment with CytD. We found that addition of the actin poly-
merization inhibitor before treatment with TPA significantly
inhibited HIV-1 transcription (>5-fold reduction); in contrast,
when HIV-1 transcription was induced before actin depolymer-
ization, no significant decrease in levels of HIV-1 transcripts
was detected (Figure 6A).672 Cell Host & Microbe 13, 665–677, June 12, 2013 ª2013 ElsevierTo prove that the inhibition of actin polymerization influences
repositioning of the viral genome from the closest PML NBs,
thus impeding the transcriptional activation of the virus, we
analyzed the spatial relationship of the HIV-1 DNA and PML by
3D immuno-DNA FISH on J-Lat 9.2 cells treated first with CytD
and thenwith TPA.Wemeasured the distances between the pro-
virus and its closest PML NB in 100 cells (representative images
are shown in Figure 6B) and normalized these values to the
nuclear diameter. We found that inhibition of actin polymeriza-
tion blocked displacement of the provirus from the PML NBs
upon TPA treatment (p < 0.001; Figure 6C).
Finally, we assessed the binding of nuclear actin to the viral
genome by ChIP. Upon TPA treatment and concomitant with
the induction of viral transcription, nuclear actin binding to the
viral promoter and to the provirus body was greatly enhanced
(Figure 6D). The levels of actin binding to the viral genome
were inversely correlated with those of PML (Figure 6E). How-
ever, when cells were treated with CytD prior to TPA, PML
protein remained bound to the viral genome, together with
H3K9met2 and G9a methyltransferase (Figures 6F and 6G,
respectively).
Taken together, these results indicate that transcriptional
activation of the silent HIV-1 is coupled with repositioning of
the provirus from PML NBs and that the inhibition of actin poly-
merization impedes both events.
DISCUSSION
A major finding reported in this manuscript is that nuclear topol-
ogy essentially regulates HIV-1 gene expression and, in partic-
ular, latency and reactivation. In latently infected T cell lines
and primary CD4+ T cells, the HIV-1 provirus is found associated
with the PML protein, as detected by both immuno-FISH and
ChIP. This interaction negatively regulates transcription bymedi-
ating association of the provirus with the G9a methyltransferase,
which modifies the HIV-1 chromatin by the H3K9me2 suppres-
sive chromatin mark. Transcriptional activation requires reposi-
tioning of the provirus away from PML NBs through a movement
involving active actin polymerization.
Association of PML bodies with specific chromosomal loci
was shown to be nonrandom in human and murine cells.
Combined immunolocalization of PML bodies with specific
in situ hybridization of cellular genomic loci has provided
convincing evidence that PML associates with certain loci with
higher frequency. For example, it was shown that the TP53
gene localizes with PML NBs in approximately 50% of Jurkat
cells (Sun et al., 2001), while the major histocompatibility
(MHC/Oct3-4) gene cluster associates with PML NBs in human
primary fibroblasts (Kumar et al., 2007; Wang et al., 2004).
While the functional significance of the colocalization of PML
NBs with cellular loci remains poorly defined in most cases, a
number of studies indicate that these nuclear structures play
an important role in the life cycles of different, nuclear-replicating
DNA viruses and of some retroviruses. In particular, parental
genomes of herpes simplex type 1 (HSV-1), human cytomegalo-
virus (HCMV), and adenovirus associate with PML NBs, which
delay or block their replication (Ahn and Hayward, 2000; Doucas
et al., 1996; Everett et al., 2007). The antiviral state is often
defined by the presence of Daxx and Sp100, permanent NBInc.
Figure 6. HIV-1 Genome Displacement from PML NBs during Transcriptional Activation Is Mediated by Polymerization of Nuclear Actin
(A) HIV-1 mRNA levels in J-LAT 9.2 cells treated with CytD followed by TPA (CytD/TPA), or the reverse (TPA/CytD), measured as in Figure 3. Data are
represented as mean ± SEM.
(B) 3D immuno-DNA FISH images of cells treated with CytD followed by TPA. HIV-1 (green) and PML (red).
(C) Quantitative analysis of the distribution of distances (n = 100 per group). ***p < 0.001. The distributions of control and CytD/TPA values are not significantly
different.
(D–G) ChIP analysis with anti-b actin (D), anti-PML (E), anti-H3K9me2 (F), and anti-G9a (G) antibodies in J-Lat cells treated for 4 hr with TPA, or with CytD for 2 hr
prior to TPA (CytD/TPA); control are mock-treated cells. p < 0.05 for all the three investigated HIV-1 regions between TPA and CytD/TPA for all four
investigated antibodies. Data are represented as mean ± SEM.
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2013) or act independently (Shalginskikh et al., 2013). Our study,
however, reveals a rather specific interaction of HIV-1 DNA with
PML, while Daxxwas not detected at the provirus and interaction
with Sp100 was weak and independent of transcriptional regula-
tion. Both PML and Sp100 are known to be induced by interferon
(IFN) (Chelbi-Alix et al., 1998); since IFN signaling exerts inhibi-
tory effects on HIV-1 replication (cf. Vendrame et al., 2009, and
citations therein), an interesting possibility is that these effects
might be, at least in part, exerted through PML induction.
Our results show that the spatial positioning of HIV-1 provirus
essentially regulates viral transcription: a negative role of PML in
viral transcription is supported by both correlative information
(spatial relationship of latent HIV-1 with PML NBs and immuno-Cell Hprecipitation of PML together with H3K9me2-marked HIV-1
chromatin) and functional data (activation of HIV-1 transcription
by disruption of PML bodies with arsenic or downregulation of
PML protein by anti-PML shRNA). PML has been shown to
repress transcription by physically and functionally interacting
with class I HDACs (Wu et al., 2001). Class I HDACs are blocked
by SAHA, and treatment with this inhibitor provokes chromatin
modifications and reduction of HDAC-1 occupancy at the
HIV-1 promoter (Archin et al., 2009, 2012). Our results show
that SAHA treatment displace the provirus from the closest
PML body, thus suggesting that PML might act together with
class I HDACs to repress HIV-1 transcription. In line with this
possibility, our previously published work has shown that
changes in the histone acetylation patterns precede the onsetost & Microbe 13, 665–677, June 12, 2013 ª2013 Elsevier Inc. 673
Cell Host & Microbe
PML Proximity Represses HIV-1 Transcriptionof productive transcription (Lusic et al., 2003), thus suggesting
that repositioning of the viral genome from the PML NB occurs
before transcriptional activation of the viral promoter. The ChIP
experiments indicating direct or indirect binding of PML to
HIV-1 chromatin appear to be rather specific, since, under the
same conditions, none of the tested control genomic regions
(B13 region on chromosome 19, shown in Figure 4; region B48
of the TIMP13 promoter, NPLOC4 gene, and a lamin-associated
region in chromosome 9p21.1, data not shown) scored positive
for this association. In addition, binding was lost upon HIV-1
transcriptional activation.
A large number of transcription factors and cofactors are
described to be recruited to the PML NBs or in their proximity;
thus, PML NBs may be viewed as chromatin-close deposit sites
for sequestration or release of factors required for transcriptional
activation or repression (Van Damme et al., 2010). This notion
appears compatible with the reported role of PML as a transcrip-
tional coactivator in certain circumstances (Chuang et al., 2011;
Lo et al., 2008) and corepressor in others (Seeler et al., 1998; Val-
lian et al., 1998). As far as the HIV-1 provirus is concerned, we
have already observed that PML plays a negative role in its
transcriptional regulation. In particular, we reported that the
overexpression of Cyclin T1 (the cyclin component of the
P-TEFb kinase, essential for HIV-1 transcription) forces localiza-
tion of this protein into PML NBs and represses transcription
(Marcello et al., 2003) and that a transcriptionally inactive form
of CDK9, the kinase component of P-TEFb, acetylated in its
catalytic domain, specifically resides inside PML NBs (Sabo`
et al., 2008). These results reinforce the conclusion that PML rep-
resents a nuclear neighborhood that is repressive for HIV-1
transe´cription.
Transcriptional silencing, as the principal feature of HIV-1
latency, can be achieved and maintained through mechanisms
involving epigenetic changes of chromatin (Lusic et al., 2003).
Latent HIV proviruses were shown to carry trimethylated histone
H3 on either lysine 9 (H3K9met3) or lysine 27 (H3K27met3), as
well as H3K9met2 (Archin et al., 2009; du Che´ne´ et al., 2007;
Imai et al., 2010). In particular, here we show that H3K9met2, a
modification associated with facultative heterochromatin that
labels the genes poised for transcription (Trojer and Reinberg,
2007), marks the latent HIV-1 chromatin, concomitant with its
association with PML and with the major H3K9met2 methyl-
transferase G9a. This finding is in perfect agreement with a
recent report showing that a chemical inhibitor of G9a was
able to reactivate HIV-1 from latency (Imai et al., 2010). Interest-
ingly, we found that presence of the PML protein and integrity of
PML NBs were essential requisites for G9a to associate with the
latent HIV-1 proviral DNA. This information is consistent with the
conclusion that the interaction of G9a with the viral genome and
the consequent repressive methylation of its chromatin is medi-
ated by PML. Considering that PML has been reported to be
involved in chromatin organization on certain genomic regions
(Kumar et al., 2007) and genes (Chuang et al., 2011), one might
hypothesize that PML contributes to chromatin organization of
those genes which are poised for transcription and become
rich in facultative chromatin marks.
G9a is not the only histone methyltransferase described to
associate with latent HIV-1; Suv39H1 and its associating factors
such as HP1 proteins were also found to accumulate in the vicin-674 Cell Host & Microbe 13, 665–677, June 12, 2013 ª2013 Elsevierity of the latent provirus (du Che´ne´ et al., 2007). Although we
could detect H3K9me3, the major modification imparted by
Suv39H1, at the silenced viral genome, wewere unable to estab-
lish a clear pattern for this histonemark upon transcriptional acti-
vation (data not shown). It is, however, apparent from different
studies, including this one, that heterogenous epigenetic modifi-
cations contribute to the silencing of HIV-1 in latent cells (Archin
et al., 2009; du Che´ne´ et al., 2007; Imai et al., 2010).
Reactivation of viral transcription upon induction is followed by
loss of PML and G9a interaction with the viral sequences and,
most significantly, by the repositioning of the provirus away
from PML NBs. When we tested whether gene movements
were involved in reactivation of HIV-1 transcription, by inhibiting
actin polymerization, we observed that HIV-1 transcription could
not be reactivated and that the virus remained closely attached
to its closest PML NB. Movement of chromatin inside the
nucleus is progressively being appreciated as important for the
regulation of gene expression. In yeast, activated genes are re-
positioned to the nuclear pore complex for RNA export (Taddei
et al., 2006). During transcriptional silencing, genes in lymphoid
cells move near centromeric heterochromatin, whereas tran-
scriptional activation of the b-globin locus involves movement
of the gene away from centromeric heterochromatin (Kosak
et al., 2002). IgH and Igk loci are localized at the nuclear periph-
ery in hematopoietic progenitors but move internally during tran-
scriptional activation during B cell development (Brown et al.,
1997). Actively transcribed genes are also brought into close
contact with nuclear speckles, sites considered to be hubs of
RNA metabolism (Brown et al., 2008). Thus, the HIV-1 provirus
joins the probably still very partial lists of gene sequences that
are essentially regulated at the transcriptional level by nuclear
topology. Despite the significant number of examples connect-
ing gene movement with changes in transcriptional activity, it
is still unclear whether intranuclear movement of chromatin is
the cause or result of changes in transcriptional activity. Nuclear
forms of actin and myosin have been implicated in mediating
long-range, directed movements (Chuang et al., 2006; Dundr
et al., 2007; Miyamoto et al., 2011), while, at the same time,
mounting evidence shows their role in cellular transcription,
chromatin remodeling, and mRNA export (Visa and Percipalle,
2010).
Which molecular mechanisms are physically linking transcrip-
tional activation, actin polymerization, andmovement away from
PML bodies, as well as the understanding of whether actin poly-
merization impacts on transcriptional initiation or elongation,
clearly requires further investigation. In this respect, however, it
appears interesting to consider that previous reports have indi-
cated that actin directly interacts with p65/RelA of NF-kB (Are
et al., 2000; Fazal et al., 2007). It is therefore tempting to specu-
late that this factor might bridge the HIV-1 LTR enhancer region
with nuclear actin.
Finally, our findings regarding the repressive nature of PML
protein and especially the strong capacity of arsenic trioxide to
mediate viral transcriptional activation by inducing PML degra-
dation might be of potential therapeutic interest. Arsenic trioxide
is an ancient drug used in the Chinese traditional medicine,
which exerts a substantial anticancer activity in patients with
acute PML by promoting PML-RARa degradation (Zhang et al.,
2010). The potential of arsenic to degrade PML can be exploredInc.
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hibitors (Margolis, 2011), to reactivate the latent viral reservoir
followed by effective antiretroviral therapy, having the ultimate
aim to achieve virus eradication.
EXPERIMENTAL PROCEDURES
Primary Cell Isolation and Culture
Peripheral blood mononuclear cells (PBMCs), obtained from healthy blood
donors after approval by the Ethical Committee of the Azienda Ospedaliero-
Universitaria ‘‘Ospedali Riuniti di Trieste,’’ Italy, were isolated as described
(Manganaro et al., 2010). For the details of CD4+ purification and culture,
see the Supplemental Experimental Procedures.
Virus Production and Infection
Viral stocks were generated using the env molecular clone pNL4-3/ER, a
kind gift from Dr. Nathaniel Landau. Details on virus production and infection
are reported in the Supplemental Experimental Procedures.
3D Immuno-DNA FISH
Three-dimensional FISH and immunostaining were performed as described
(Solovei and Cremer, 2010), with the modifications reported in the Supple-
mental Experimental Procedures.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Perkins et al., 2008), with some
modifications introduced for J-Lat cells (see the Supplemental Experimental
Procedures).
Coimmunoprecipitation
Immunoprecipitations of endogenous G9a were performed using the J-Lat 9.2
nuclear extracts, whereas for exogenously expressed PML protein HEK293T
cells were used (as reported in the Supplemental Experimental Procedures).
qRT-PCR
For the quantification of HIV transcript levels, RNA was purified from the cells
with the NucleoSpin RNA II purification kit (Macherey-Nagel), and the mRNA
levels were quantified by TaqMan qRT-PCR by using HIV-1 primers and
probes (Perkins et al., 2008) and housekeeping gene controls (GAPDH
and18S rRNA).
RNA Sequencing
For the transcriptomic analysis, total RNA was extracted from untreated 9.2
J-Lat cells, cells treated with TPA for 5 hr, and from a J-Lat 9.2-derived stable
clone expressing shPML.
Deep sequencing was performed by IGA Technology Services (Udine, Italy).
Samples were processed using TruSeq RNA-seq sample prep kit from Illumina
(Illumina, Inc.), and CLC-Bio Genomics Workbench software (CLC Bio) was
used to calculate gene expression levels (see the Supplemental Experimental
Procedures for details).
Flow Cytometry Analysis
Cell fluorescence was measured with the FACSCalibur (BD Bioscience). To
phenotype CD4+ T cells, these were stained with the following mABs: FITC-
conjugated anti-CD4+, PerPC-conjugated anti-CD45RA, and phycoerythrin-
conjugated (PE)-anti CD45RO (Miltenyi Biotec). Flow cytometry data were
analyzed with FlowJo software or Cellquest (BD Bioscience). Analysis was
restricted to the live population, as defined by the forward versus side scatter
profile.
Arsenic Toxicity Test
To test the toxicity of arsenic on primary CD4+ T cells and on J-Lat 9.2 cells, the
cellular adenosine triphosphate (ATP) levels were measured by a lumines-
cence assay (ATPlite, Perkin Elmer). Cells (8 3 104) were cultured for 24 hr in
medium containing different concentration of arsenic trioxide (1, 2, and
10 mM). After cell lysis, ATP concentration was measured as luminescence
according to the manufacturers’ protocol.Cell HStatistical Analysis
Statistical analysis was performed using R software (http://www.r-project.
org/) and Prism 4. Statistical analysis of FISH signals was performed by
applying the Mann-Whitney-Wilcoxon rank sum test. Star code for statistical
significance is as follows: ***p < 0.001, **p < 0.01,*p < 0.05.
For the ChIP and RT-PCR results, the reported values are mean and
standard error of the mean (SEM), calculated from at least three independent
samples. Statistical significance was evaluated using one-way ANOVA and
Bonferroni/Dunn’s post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
at http://dx.doi.org/10.1016/j.chom.2013.05.006.
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